Robert Murphy
North Little Rock, ARNPI 1356381982
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,948 of the $3,512 with a category attached, or 83.9%. 16 manufacturers reported payments, led by AbbVie at 32.6% of the total.
Across 196 payments — averaging $17.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Braintree Laboratories, Inc.$512
- Johnson & Johnson$476
- Pfizer$254
- Takeda Pharmaceuticals U.S.A., Inc.$243
- Gilead$177
- plus $703 from 10 others
Across 171 payments — averaging $4631.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$187K
- AbbVie$185K
- Gilead$178K
- Braintree Laboratories, Inc.$102K
- Shire North American Group Inc$83K
- Ironwood Pharmaceuticals, Inc$40K
- plus $16K from 1 others
What the payments were for
- Food & beverage$2,94884%
- Education$1003%
- Gifts$46413%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 81 | $1,146 |
| Braintree Laboratories, Inc. | 12 | $512 |
| Johnson & Johnson | 26 | $476 |
| Pfizer | 15 | $254 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $243 |
| Gilead | 12 | $177 |
| Janssen Scientific Affairs, LLC | 2 | $105 |
| Intercept Pharmaceuticals, Inc. | 6 | $101 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $99 |
| Bristol Myers Squibb | 6 | $91 |
| Redhill Biopharma Inc. | 4 | $87 |
| Merck | 5 | $85 |
| Regeneron Healthcare Solutions, Inc. | 2 | $70 |
| Nestle Healthcare Nutrition Inc. | 2 | $30 |
| Ardelyx, Inc. | 1 | $21 |
| Boehringer Ingelheim | 1 | $14 |
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 19 | $271 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.